A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

NCT05259033 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

683

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: IcoSema
DRUG: Semaglutide 1 mg

Sponsor

Novo Nordisk A/S